Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Alnylam’s givosiran gets FDA priority review for acute hepatic porphyria
Image: FDA grants priority review for Alnylam’s givosiran in acute hepatic porphyria. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org.
Image: FDA grants priority review for Alnylam’s givosiran in acute hepatic porphyria. Photo: courtesy of The U.S. Food and Drug Administration/Wikipedia.org.